GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (BSP:LILY34) » Definitions » Cyclically Adjusted FCF per Share

Eli Lilly and Co (BSP:LILY34) Cyclically Adjusted FCF per Share : R$0.60 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Eli Lilly and Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Eli Lilly and Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was R$0.015. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$0.60 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Eli Lilly and Co's average Cyclically Adjusted FCF Growth Rate was -20.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -2.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 0.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Eli Lilly and Co was 19.60% per year. The lowest was -2.70% per year. And the median was 7.40% per year.

As of today (2024-05-16), Eli Lilly and Co's current stock price is R$133.90. Eli Lilly and Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$0.60. Eli Lilly and Co's Cyclically Adjusted Price-to-FCF of today is 223.17.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Eli Lilly and Co was 222.00. The lowest was 13.08. And the median was 28.25.


Eli Lilly and Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Eli Lilly and Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Cyclically Adjusted FCF per Share Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.65 0.75 0.76 0.57

Eli Lilly and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.69 0.66 0.57 0.60

Competitive Comparison of Eli Lilly and Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Cyclically Adjusted Price-to-FCF falls into.



Eli Lilly and Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.015/129.4194*129.4194
=0.015

Current CPI (Mar. 2024) = 129.4194.

Eli Lilly and Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.055 100.560 0.071
201409 0.098 100.428 0.126
201412 0.055 99.070 0.072
201503 -0.046 99.621 -0.060
201506 0.057 100.684 0.073
201509 0.095 100.392 0.122
201512 0.054 99.792 0.070
201603 -0.043 100.470 -0.055
201606 0.124 101.688 0.158
201609 0.147 101.861 0.187
201612 0.162 101.863 0.206
201703 -0.065 102.862 -0.082
201706 0.149 103.349 0.187
201709 0.142 104.136 0.176
201712 0.132 104.011 0.164
201803 0.021 105.290 0.026
201806 -0.042 106.317 -0.051
201809 0.243 106.507 0.295
201812 0.105 105.998 0.128
201903 -0.012 107.251 -0.014
201906 0.107 108.070 0.128
201909 0.175 108.329 0.209
201912 0.245 108.420 0.292
202003 0.020 108.902 0.024
202006 0.374 108.767 0.445
202009 0.275 109.815 0.324
202012 0.187 109.897 0.220
202103 0.248 111.754 0.287
202106 0.229 114.631 0.259
202109 0.227 115.734 0.254
202112 0.359 117.630 0.395
202203 0.301 121.301 0.321
202206 0.069 125.017 0.071
202209 0.303 125.227 0.313
202212 0.198 125.222 0.205
202303 0.159 127.348 0.162
202306 -0.037 128.729 -0.037
202309 -0.331 129.860 -0.330
202312 -0.355 129.419 -0.355
202403 0.015 129.419 0.015

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Eli Lilly and Co  (BSP:LILY34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Eli Lilly and Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=133.90/0.6
=223.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Eli Lilly and Co was 222.00. The lowest was 13.08. And the median was 28.25.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Eli Lilly and Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (BSP:LILY34) Business Description

Industry
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (BSP:LILY34) Headlines

No Headlines